Targeting mutant p53 with COTI-2: A new approach for the treatment of patients with triple-negative breast cancer?

e13121Background: The identification of a targeted therapy for patients with triple-negative breast cancer (TNBC) is one of the most urgent needs in breast cancer therapeutics. Since the p53 gene i...